Luye Pharma Group (HK:2186) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Luye Pharma Group has announced plans to issue convertible bonds worth $150 million, with a 5.85% interest rate due in 2025. The proceeds will be used for refinancing existing debt, research and development, and general corporate purposes. The bonds, which can be converted into shares, are part of a strategic move to strengthen the company’s financial position.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
